The Uncertain Resiliency of Public Trust in Science
In recent years, media coverage has suggested that attacks on science eroded confidence in institutions. But did they? According to the latest research, public trust in scientists mostly survived the...
View ArticleTrump’s Executive Orders Seek to Erase Scientific Truth
Despite containing language about scientific progress and the pursuit of truth, several of the White House’s recent executive orders contradict biological evidence on sex, gender, and race. One...
View ArticleCarbon Capture Scale Up Brings New Problems to the Midwest
By hiding its emissions underground, the ethanol industry hopes to cling on indefinitely. But the rapid expansion of geologic carbon storage is bringing a new set of problems to the Midwest.
View ArticleInterview: How Elon Musk Blurs the Lines of Free Speech
In an interview with Undark, legal expert Ari Cohn says we are heading into uncharted waters in regard to First Amendment rights as social media giants expand their reach and the distinction between...
View ArticleWhere Did U.S. Public Health Go Wrong?
In early 20th century, public health had great success in preventing disease and death. But in the decades that followed, progress stalled when its attempts to integrate with medicine failed. One...
View ArticleReview: When the USSR and America Joined in the Search for ET
Historian Rebecca Charbonneau, in “Mixed Signals: Alien Communication Across the Iron Curtain,” examines an unusual alliance of interests during the Cold War, when Soviet and American scientists worked...
View ArticleAs Adults Age With MS, Should They Shed Their Meds?
Since the 1990s, more than two dozen drugs have been approved to treat multiple sclerosis. But a question looms: For older adults — who are less likely to suffer the disease’s hallmark flare-ups, and...
View ArticleIn New Administration, Supplement Makers See Chance To Cash In
Robert F. Kennedy Jr. has said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances. The $70 billion industry...
View ArticleIn New Administration, Supplement Makers See Chance To Cash In
Robert F. Kennedy Jr. has said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances. The $70 billion industry...
View ArticleIn Digital Genetic Data, An Uncertainty Over Ownership
The existing legal framework over who owns genetic resources was not designed for the digital age. And although international negotiators have wrangled over digital sequence information for many years,...
View ArticleIn New Administration, Supplement Makers See Chance To Cash In
Robert F. Kennedy Jr. has said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances. The $70 billion industry...
View ArticleHow Science Can Adapt to a New Normal
Layoffs and funding freezes have struck a blow to the U.S. scientific enterprise. Selective Pressure columnist C. Brandon Ogbunu argues that to mitigate the damage, scientists need to swiftly adopt a...
View ArticleInterview: Did Scientists and the Media Get Covid All Wrong?
Is it possible that many scientists and the news media got the Covid-19 response all wrong? Political scientists Stephen Macedo and Frances Lee, the authors of “In Covid’s Wake,” argue that many...
View ArticleIn New Administration, Supplement Makers See Chance To Cash In
Robert F. Kennedy Jr. has said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances. The $70 billion industry...
View ArticleNIH Funding Cuts Don’t Just Target Elite Universities
When the National Institutes of Health announced on social media that it would reduce funding for biomedical research grants, the agency pointed to elite universities and their hefty endowments. But...
View ArticleIn New Administration, Supplement Makers See Chance To Cash In
Robert F. Kennedy Jr. has said the Trump administration would liberate Americans from the FDA’s “aggressive suppression” of vitamins, dietary supplements, and other substances. The $70 billion industry...
View ArticleFederal Science Hamstrung by DOGE’s Credit Card Spending Limit
Elon Musk’s agency froze most spending above $1 on federal credit cards. Now, officials and researchers at science agencies are struggling to order basic supplies and carry out the main functions of...
View ArticleRural Texas Scrambles to Respond to Measles
With crumbling public health infrastructure, county health departments in Texas face steep challenges. Aging infrastructure, a dearth of primary care providers, and long distances between testing sites...
View ArticleInfertility Is a Mental Health Bombshell
In February, the White House issued an executive order meant to protect access to in vitro fertilization and reduce costs for IVF treatments. But it doesn’t address the emotional burden often...
View ArticleBook Review: How Our Digital Infatuation Undermines Discourse
Technology writer Nicholas Carr contends in “Superbloom” that our obsession with digital technology is causing us to live in a perpetual state of sensory and communication overload. In the process, our...
View Article